Form D · Biotechnology
Twister Biotech, Inc.
Houston, TX · CIK 0001716382
Offering snapshot reported Aug 28, 2023 · SEC filing
- Reported sold
- $500K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Aug 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2023 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jan 11, 2021 | Initial | $1,115,305 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490804
Source: Form D, filed Aug 28, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Coker | Director, Executive |
| Evan Davies | Director |
| Mark Matovich | Director |
| Michael Pavia | Director |
| Alex Steven | Director, Executive |
| Lynn Zechiedrich | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4108 Lillian St., Unit B
Houston, TX, 77007
Houston, TX, 77007